RELMADA THERAPEUTICS, INC. Increase (Decrease) in Prepaid Expenses, Other
RELMADA THERAPEUTICS, INC. (RLMD) reported Increase (Decrease) in Prepaid Expenses, Other of -$637.03 thousand for the 6-month period ending 2024-06-30, per its 10-Q filed 2024-08-07.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpensesOther · last filed 2024-08-07
- RELMADA THERAPEUTICS, INC. increase (decrease) in prepaid expenses, other for the quarter ending 2017-06-30 was -$59.79K.
- RELMADA THERAPEUTICS, INC. increase (decrease) in prepaid expenses, other for the quarter ending 2017-03-31 was -$94.23K.
- RELMADA THERAPEUTICS, INC. increase (decrease) in prepaid expenses, other for the quarter ending 2016-12-31 was -$166.00K.
- RELMADA THERAPEUTICS, INC. increase (decrease) in prepaid expenses, other for the quarter ending 2016-09-30 was -$50.31K.
- RELMADA THERAPEUTICS, INC. increase (decrease) in prepaid expenses, other for fiscal 2017 was -$370.33K.
- RELMADA THERAPEUTICS, INC. increase (decrease) in prepaid expenses, other for fiscal 2016 was -$1.19M, a 198.55% decline from fiscal 2015.
- RELMADA THERAPEUTICS, INC. increase (decrease) in prepaid expenses, other for fiscal 2015 was $1.21M.
- RELMADA THERAPEUTICS, INC. increase (decrease) in prepaid expenses, other for fiscal 2013 was -$160.28K, a 187.73% decline from fiscal 2012.
| Period end | Increase (Decrease) in Prepaid Expenses, Other 3 month | Increase (Decrease) in Prepaid Expenses, Other 6 month | Increase (Decrease) in Prepaid Expenses, Other 6 month as first filed | Increase (Decrease) in Prepaid Expenses, Other 9 month | Increase (Decrease) in Prepaid Expenses, Other 12 month | Increase (Decrease) in Prepaid Expenses, Other 12 month as first filed | Increase (Decrease) in Prepaid Expenses, Other 115 month | Increase (Decrease) in Prepaid Expenses, Other 118 month |
|---|---|---|---|---|---|---|---|---|
| 2024-06-30 | -$637.03K 10-Q · filed 2024-08-07 | |||||||
| 2023-06-30 | -$560.93K 10-Q · filed 2024-08-07 | |||||||
| 2017-06-30 | -$59.79K derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-28 | -$154.02K derived: sum of 2 quarters · filed 2017-09-28 | -$320.02K derived: sum of 3 quarters · filed 2017-09-28 | -$370.33K 10-K · filed 2017-09-28 | ||||
| 2017-03-31 | -$94.23K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-15 | -$260.23K derived: sum of 2 quarters · filed 2017-05-15 | -$310.54K 10-Q · filed 2017-05-15 | -$443.14K derived: sum of 4 quarters · filed 2017-09-28 | ||||
| 2016-12-31 | -$166.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-10 | -$216.31K 10-Q · filed 2017-02-10 | -$348.91K derived: sum of 3 quarters · filed 2017-09-28 | -$450.40K derived: sum of 4 quarters · filed 2017-09-28 | ||||
| 2016-09-30 | -$50.31K 10-Q · filed 2016-11-10 | -$182.91K derived: sum of 2 quarters · filed 2017-09-28 | -$284.40K derived: sum of 3 quarters · filed 2017-09-28 | -$640.27K derived: sum of 4 quarters · filed 2017-09-28 | ||||
| 2016-06-30 | -$132.60K derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-28 | -$234.09K derived: sum of 2 quarters · filed 2017-09-28 | -$589.96K derived: sum of 3 quarters · filed 2017-09-28 | -$1.19M 10-K · filed 2017-09-28 | -$959.96K 10-K · filed 2016-09-09 | |||
| 2016-03-31 | -$101.49K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-15 | -$457.37K derived: sum of 2 quarters · filed 2017-05-15 | -$1.06M 10-Q · filed 2017-05-15 | -$294.38K derived: sum of 4 quarters · filed 2017-05-15 | ||||
| 2015-12-31 | -$355.87K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-10 | -$957.81K 10-Q · filed 2017-02-10 | $957.81K 10-Q · filed 2016-02-05 | -$192.88K derived: sum of 3 quarters · filed 2017-02-10 | $1.18M derived: sum of 4 quarters · filed 2017-02-10 | |||
| 2015-09-30 | -$601.93K 10-Q · filed 2016-11-10 | $162.99K derived: sum of 2 quarters · filed 2016-11-10 | $1.53M derived: sum of 3 quarters · filed 2016-11-10 | $596.46K derived: sum of 4 quarters · filed 2016-11-10 | ||||
| 2015-06-30 | $764.92K derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-09 | $2.13M derived: sum of 2 quarters · filed 2016-09-09 | $1.20M derived: sum of 3 quarters · filed 2016-09-09 | $1.21M 10-K · filed 2016-09-09 | ||||
| 2015-03-31 | $1.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-09 | $433.48K derived: sum of 2 quarters · filed 2016-05-09 | $444.53K 10-Q · filed 2016-05-09 | $500.03K derived: sum of 4 quarters · filed 2016-05-09 | ||||
| 2014-12-31 | -$934.93K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-05 | -$923.87K 10-Q · filed 2016-02-05 | -$868.38K derived: sum of 3 quarters · filed 2016-02-05 | -$833.89K derived: sum of 4 quarters · filed 2016-02-05 | ||||
| 2014-09-30 | $11.06K 10-Q · filed 2015-11-06 | $66.55K derived: sum of 2 quarters · filed 2015-11-06 | $101.04K derived: sum of 3 quarters · filed 2015-11-06 | |||||
| 2014-06-30 | $55.49K derived: 10-K 6 month − 8-K 3 month · filed 2015-09-11 | $89.98K 10-K · filed 2015-09-11 | ||||||
| 2014-03-31 | $34.49K 8-K · filed 2014-05-27 | $56.92K 8-K · filed 2014-05-27 | ||||||
| 2013-12-31 | -$160.28K 10-K · filed 2015-09-11 | $22.43K 8-K · filed 2014-05-27 | ||||||
| 2013-09-30 | -$10.56K 10-Q · filed 2014-11-07 | |||||||
| 2013-03-31 | -$153.24K 8-K · filed 2014-05-27 | |||||||
| 2012-12-31 | $182.71K 10-KT · filed 2014-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |